Filtered By:
Cancer: Lymphoma
Management: Insurance
This page shows you your search results in order of date.
Order by Relevance | Date
Total 76 results found since Jan 2013.
Descriptive Analysis and Factors Influencing Survival in Patients With Primary Cutaneous Gamma-Delta T Cell Lymphoma. A Retrospective National Cancer Database Study
CONCLUSION: Socioeconomic disparities significantly impact access to healthcare and are of particular importance in rare lymphomas.PMID:37690902 | DOI:10.1016/j.clml.2023.08.015
Source: Clinical Lymphoma and Myeloma - September 10, 2023 Category: Cancer & Oncology Authors: Prashanth Ashok Kumar Abirami Sivapiragasam Dongliang Wang Danning Huang Teresa Gentile Source Type: research
Retrospective Case-Control Study of REGEN-COV (casirivimab and imdevimab) Therapy for Patients with COVID-19 and Cancer Using the United States MarketScan ® Database
Conclusion Patients with cancer treated with REGEN-COV experienced a decreased risk for hospitalization, hospitalization duration, and total COVID-19-related costs. Patients with cancer were at a higher risk of being hospitalized for COVID-19 than were those without cancer. The use of neutralizing antibody therapy may reduce the risk of severe COVID-19 infection for patients with cancer with an otherwise high risk. Future replication studies should be conducted using other databases that include Medicaid users and other insured persons for comparison and validation.PMID:37666220 | DOI:10.1159/000533614
Source: Oncology - September 4, 2023 Category: Cancer & Oncology Authors: Kazue Takemoto Source Type: research
Disparities in Multiple Myeloma Treatment Patterns in the United States: A Systematic Review
Clin Lymphoma Myeloma Leuk. 2023 Aug 13:S2152-2650(23)00255-0. doi: 10.1016/j.clml.2023.08.008. Online ahead of print.ABSTRACTWe performed a systematic review of the literature investigating the demographic and insurance-related factors linked to disparities in multiple myeloma (MM) care patterns in the United States from 2003 to 2021. Forty-six observational studies were included. Disparities in MM care patterns were reported based on patient race in 76% of studies (34 out of 45 that captured race as a study variable), ethnicity in 60% (12 out of 20), insurance in 77% (17 out of 22), and distance from treating facility, u...
Source: Clinical Lymphoma and Myeloma - September 2, 2023 Category: Cancer & Oncology Authors: Hamlet Gasoyan Mark A Fiala Michelle Doering Ravi Vij Michael Halpern Graham A Colditz Source Type: research
Cost-effectiveness of combination therapy of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisolone for previously untreated diffuse large B-cell lymphoma in Japan
CONCLUSIONS: This study suggests that Pola + R-CHP is a cost-effective treatment for previously untreated DLBCL in Japan under the public health insurance system.PMID:37656225 | DOI:10.1080/13696998.2023.2254162
Source: Journal of Medical Economics - September 1, 2023 Category: Health Management Authors: Takashi Mizuoka Hiroyuki Sakamaki Shigeo Fuji Shota Saito Tatsunori Murata Shinya Ohno Naoki Inubashiri Tomoha Oshima Kazuhito Yamamoto Source Type: research
Disparities in Time to Diagnosis Among Patients With Multiple Myeloma
CONCLUSION: This study suggests there may be socioeconomic disparities in TTD among patients with MM. Interventions such as patient navigation may be useful to reduce TTD among socioeconomically disadvantaged patient populations. Further studies need to be conducted to elucidate reasons for delays.PMID:37612207 | DOI:10.1016/j.clml.2023.08.003
Source: Clinical Lymphoma and Myeloma - August 23, 2023 Category: Cancer & Oncology Authors: Olivia M Lin Dana Paine Esther Gramling Manoj Menon Source Type: research
Incidence and Features of Lymphoid Proliferation and Lymphomas after Solid Organ or Hematopoietic Stem Cell Transplantation in a National Database Cohort
CONCLUSION: We observed a steady increase in PTLD over 10 years after HCT or SOT in this large cohort study. Pediatric age group, HCT, liver transplantation, and heart transplantation were suggested to be risk factors for PTLD, and PTLD was associated with a higher risk of death.PMID:37475137 | DOI:10.4143/crt.2023.647
Source: Cell Research - July 21, 2023 Category: Cytology Authors: Seung Min Hahn Myeongjee Lee JongHoon Hyun Sungmin Lim Ji-Man Kang Jong Gyun Ahn Dong Jin Joo Inkyung Jung Kyong Ihn Source Type: research
